Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: Ga Bard who wrote (729)	5/6/1998 12:30:00 AM
From: Jeffrey L. Henken	Read Replies (2) \| Respond to of 2887

Looking for a competitive product? Has anyone else got a product like the OmniFilter in R&D? This exciting product could be on the market by early 1999: americanbiomed.com The OmniFilter, a percutaneous guidewire microfilter that converts a standard guidewire into a temporary microemboli filter, is designed to prevent stroke-causing blood clots from reaching various organs of the body. Its patented "purse string" closure secures clot removal without loss into the blood stream, and its cost-effective design reduces the chance of stroke and prevents distal embolization. Industry analysts estimate a $500 million annual worldwide market for carotid angioplasty applications using this technology, with the U.S. representing approximately one-half of the worldwide market. GO ABMI! Regards, Jeff